APA (7th ed.) Citation

MJ, C., JS, R., ME, M., & P, G. (2010). Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk. Pharmacology & therapeutics, 126(3), 314. https://doi.org/10.1016/j.pharmthera.2010.01.008

Chicago Style (17th ed.) Citation

MJ, Chapman, Redfern JS, McGovern ME, and Giral P. "Niacin and Fibrates in Atherogenic Dyslipidemia: Pharmacotherapy to Reduce Cardiovascular Risk." Pharmacology & Therapeutics 126, no. 3 (2010): 314. https://doi.org/10.1016/j.pharmthera.2010.01.008.

MLA (9th ed.) Citation

MJ, Chapman, et al. "Niacin and Fibrates in Atherogenic Dyslipidemia: Pharmacotherapy to Reduce Cardiovascular Risk." Pharmacology & Therapeutics, vol. 126, no. 3, 2010, p. 314, https://doi.org/10.1016/j.pharmthera.2010.01.008.